🇺🇸

US SEC Filing Intelligence

· daily

Federal Professional Services Contracts — March 13, 2026

Five bullish federal professional services contracts total $757M in obligations, with GSA dominating (4/5 awards) and SAIC capturing 58% ($447M across two deals), signaling entrenched positioning for large contractors in engineering and admin services. Unexercised options offer $309M+ upside potential across the portfolio, while long-duration awards (e.g., Ameresco to 2047) highlight stable revenue visibility amid disaster response and energy retrofit priorities. Risks center on execution in extended periods and high subcontract pass-throughs (up to $457M in one deal), but early outlays in recent awards like Fluor's $77M indicate funding momentum.

5 total filings
· daily

Federal IT & Cybersecurity Contracts — March 13, 2026

Four bullish federal IT/cybersecurity contracts total $318.98M obligated (avg 70% outlayed), signaling robust execution and demand from HHS ($172.5M), VA ($78.7M), and DOJ ($67.8M). Firm fixed price delivery orders feature $521.47M potential via options, extending to 2029 and adding ~64% upside. Mix of large (GD, Iron Vine) and small businesses (SparkSoft, Seneca) winning full/open comp highlights sector accessibility and multi-year revenue visibility.

4 total filings
· daily

New Federal Contractors — March 13, 2026

This batch of 21 new federal contracts totals $3.6B in obligations, with 17 bullish signals dominated by long-term health R&D, border security construction, and IT/cybersecurity services, providing revenue visibility through 2047. Public companies like SAIC ($446.8M across two awards), Fluor, General Dynamics IT, Northrop Grumman, Ameresco, and CoreCivic capture ~15% of value with options upside averaging 40% above obligations. Firm fixed price structures prevail (70% of contracts), flagging execution risks amid low average outlays (22% of obligated).

21 total filings
· daily

Significant Contract Modifications ($10M+) — March 13, 2026

Federal contract modifications totaling $3.6B signal robust demand in border infrastructure ($618M), health R&D/services ($1.1B+), and IT/cybersecurity ($500M+), with 17 bullish signals dominated by long-term awards to public firms like SAIC ($447M across 2), Fluor, and CoreCivic. Revenue visibility extends to 2047 for energy retrofits and 2031 for stewardship/embassies, though firm-fixed-price prevalence (14/21) heightens execution risks amid low average outlays (26% of obligations). Investors should prioritize defense/IT primes and construction for near-term cash flows, monitoring option exercises adding $1.5B+ potential value.

21 total filings
· daily

Contract Deobligations Alert — March 13, 2026

This $3.6B contract deobligations alert reveals 17 bullish signals dominated by long-term federal obligations in health services, border infrastructure, and IT/cybersecurity, with total upside from unexercised options exceeding $2B across records. Publicly traded firms like SAIC (2 awards, $446.8M obligated), Fluor ($134.5M), and Northrop Grumman ($64M) show strongest direct equity exposure amid low outlays signaling potential funding restarts. Neutral signals cluster in nonprofits/low-outlay health R&D, limiting investable upside; prioritize border construction and HHS IT for near-term revenue ramps.

21 total filings
· daily

Contract Option Exercises — March 13, 2026

21 contract option exercises totaling $3.6B signal robust federal spending commitments through 2047, predominantly bullish (17/21) across HHS (health IT/cyber), DHS (border/detention/disaster), and GSA/VA (engineering/energy). Publicly traded beneficiaries like SAIC ($446.8M aggregate), Fluor, General Dynamics IT, Northrop Grumman, Ameresco, and CoreCivic gain multi-year revenue visibility amid FFP/T&M structures. Neutral signals limited to nonprofits/low outlays; prioritize monitoring option exercises ($1B+ potential) and execution on long-duration projects.

21 total filings
· daily

All HHS Contracts — March 13, 2026

HHS awarded $1.26B across 7 contracts, with 57% bullish signals concentrated in CMS-driven cybersecurity, IT development, and Medicare communications, signaling robust near-term revenue for service providers. Recent awards (2024) show rapid outlays averaging 60% of obligations, indicating execution momentum and $800M+ in unexercised options for upside. Neutral signals from nonprofits and matured contracts limit broad equity plays, prioritizing small/disadvantaged businesses in health IT and R&D.

7 total filings
· daily

Mega Contracts Monitor ($100M+) — March 13, 2026

This week's $2.85B mega contracts show 80% bullish signals, dominated by long-term federal awards in construction ($900M+ combined), health services/R&D ($1B+), and engineering/cyber ($900M+), providing multi-year revenue visibility to 2047. Public companies like SAIC, Fluor, Caddell, and Ameresco capture significant GSA/DHS/State wins with options upside averaging 30-50% above obligations. Risks center on firm-fixed-price overruns and low initial outlays (avg. 20-30% drawn), but opportunities in follow-ons and extensions outweigh for construction/energy sectors.

10 total filings
· daily

High-Value Federal Grants ($5M+) — March 13, 2026

Federal high-value contracts totaling $3.6B show 17 bullish signals dominated by long-term HHS health R&D/services ($1.2B+), DHS border/detention/disaster ($823M), and GSA engineering/IT ($886M), signaling sustained gov spending momentum into 2030+. Public companies like SAIC (2 awards, $447M), Fluor ($134M), and CoreCivic ($57M) offer direct equity upside via options/exercises averaging 30-100% above obligations. Risks center on firm fixed price structures (12/21 contracts) and low outlays in 40% of awards, but rapid disbursements in recent IT/health wins ($36-90M outlayed) indicate execution strength.

21 total filings
· daily

General Federal Contracts — March 13, 2026

21 federal contracts totaling $3.6B awarded or active, with 17 bullish signals dominated by health services (HHS/CMS/VA ~$1.5B), border/detention security (DHS/ICE ~$823M), and IT/engineering (GSA ~$934M), signaling sustained federal spending in preparedness, infrastructure, and cyber/IT amid long-term performance periods to 2047. Public companies like SAIC ($447M across 2), Fluor, Northrop Grumman, and CoreCivic gain committed revenue with options upside >$1B potential. Neutral signals limited to nonprofits/low-outlay deals; risks center on firm-fixed-price overruns and funding delays, but high outlays in recent awards ($222M+ in several) indicate execution momentum.

21 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — March 13, 2026

Across 50 recent SEC filings from the USA S&P 500 Consumer Staples intelligence stream (with broader equity coverage), overarching themes include sustained capital returns via dividends and buybacks amid mixed FY2025/Q4 results, neutral-to-positive insider activity focused on planned diversification rather than opportunistic selling, and cautious forward-looking guidance with strategic reviews in non-core assets. Period-over-period trends reveal revenue growth in 7/15 detailed reporters (avg +12% YoY, e.g., monday.com +27%, CCEP +FX-neutral), but margin compression in 6/15 (avg -100bps, e.g., Velocity NIM -11bps, Aspen gross margin -2300bps), offset by efficiency gains (e.g., Fidelity D&D efficiency ratio -590bps to 60.3%). Critical developments feature CCEP's strong €20.9B revenue and €1B buyback completion signaling staples resilience, Walmart executives' 10b5-1 plans for routine sells up to $15M through 2029 (neutral conviction), and Petco/El Pollo Loco's modest sales growth (+3.6%/-2.5%) with profitability improvements. Portfolio-level patterns show 9/50 filings with dividends/buybacks (e.g., GIII $0.10, Ford 31.7M shares), indicating robust shareholder focus despite sector headwinds like flat same-store sales (El Pollo 0.1%). M&A/strategic processes (e.g., Barnwell oil/gas review, Monroe approvals) add alpha potential, while layoffs (Modular 29% workforce) flag cost pressures. Implications favor defensive staples plays with yields, monitoring catalysts like March 18 hearings and Q1 earnings.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — March 13, 2026

Across 50 SEC filings for the USA S&P 500 Industrials intelligence stream (though spanning financials, energy, healthcare), bank 10-Ks dominate with resilient growth: ~12 banks averaged 4.5% YoY asset growth, 12% YoY NII increase, and 20bps NIM expansion (e.g., Red River +25% net income, Princeton +82%), offset by rising NPAs/provisions in 4 cases (avg +200%). Industrials shine with Venture Global's landmark $20.7B CP2 LNG financing (Phase 2 FID $8.6B, no equity needed, targeting 100+ MTPA capacity), Ducommun's record $824.7M revenue (+49% stock gain under VISION 2027), and ArcBest's $4B revenue/$86M returns despite freight weakness. Capital allocation trends positive: 5 dividends (GIII $0.10, Designer $0.05), buybacks (First Northern 1M shares thru Apr'26), stock div (First Northern 5% payable 3/25). Forward-looking catalysts include Better Home's Q1'26 loan vol guide $1.4-1.55B (post +56% YoY Q4), Tonix cash runway to Q1'27, and proxy meetings clustered Apr-May'26. Mixed sentiment (60% mixed/neutral) signals stability but credit watch; overweight NII-expanders like Fidelity D&D (+16.7% NII), avoid NPA outliers like Isabella (+553%). Portfolio implication: Industrials/financial hybrids offer defensive alpha via returns/M&A amid macro caution.

34 high priority 16 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — March 13, 2026

Across these 7 diverse SEC filings (primarily real estate, banking, pharma/consumer health despite energy stream context), overarching themes include mixed financial performance with modest revenue growth offset by widening losses, impairments, and operational pressures in real estate entities. Period-over-period trends reveal revenue increases (BRT +1.5% YoY to $97M, Copper lease income +2% YoY to $96M, John Marshall NII +18.6% YoY) but declining profitability (BRT FY net loss to $(11.9M) from $(9.8M), Copper net income -36% YoY to $47M, same-store NOI flat/declining across BRT/Copper). Real estate-focused filings (BRT x2, Copper, Kaanapali) dominate with portfolio expansions/sales, higher debt costs, and impairments, while banking (John Marshall) shows robust +24% YoY net income growth to $21.2M and Haleon delivers clean audits. Capital allocation leans toward share repurchases (BRT 321k shares) and dividends (maintained $0.25 Q at BRT, $0.30 at John Marshall), but no insider trading patterns noted. Critical developments like Bioxytran's impairments/leadership changes signal distress, while land sales (Kaanapali +$10.3M gain) and bank asset growth (+4.4% to $2.33B) offer pockets of strength. Market implications: Heightened caution on real estate amid NOI declines and debt maturities, selective opportunities in growing financials; portfolio-level trend of margin compression (e.g., Copper NOI -7%, BRT AFFO flat) suggests broader sector vulnerability.

6 high priority 1 medium 7 total filings
· daily

S&P 500 Financials Sector SEC Filings — March 13, 2026

Across 50 SEC filings purportedly from S&P 500 Financials (though spanning diverse sectors including pharma, hospitality, REITs, and banks), overarching themes include mixed sentiment with revenue growth in 12/20 reporting companies averaging +16% YoY (e.g., ONE Group +19.7%, Emerald +16.2%, Jefferson Capital +41.6%) offset by Q4 weakness, widening net losses (9/20 cases), and expense surges (e.g., Tonix SG&A +119%). True financials like Red River Bancshares (+25% net income, NIM +14bps to 3.38%), First Northern (+4.8% NII, NIM +17bps), Republic Bancorp (NPS +12% to 73.4), and Jefferson Capital (+45.8% net income) show resilience amid deposit declines elsewhere. Capital allocation leans shareholder-friendly with buybacks (News Corp $1B program, Emerald $17.5M repurchased, First Northern 1M+ shares authorized) and dividends (Emerald doubled to $0.06/share, BRT $0.25 Q). Insider activity limited to routine Walmart 10b5-1 plans (e.g., McMillon 155k shares). Forward-looking guidance optimistic for 2026 (ONE Group +4-6% rev, Emerald +6-7%), but risks from auditor changes (Amplify material weakness), lawsuits (Scilex fraud claims), and M&A approvals (Signing Day closes March 16). Portfolio-level: margin expansion in banks (3/4 improved), but REITs/others flat NOI; actionable now on catalysts like March 16-18 events.

30 high priority 20 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — March 13, 2026

The 50 8-K filings from March 13, 2026, reveal a surge in financing activities (12+ cases), including credit expansions, note issuances, and debt-for-equity swaps, signaling robust liquidity amid stable economic conditions; energy firms dominate positive developments with accretive acquisitions and $20.7B+ project financings. Executive transitions affect 15+ companies (resignations/appointments), mostly neutral/mixed but clustered in tech/healthcare, potentially signaling churn without major disagreements. Capital allocation trends favor shareholders via $10M repurchases (HealthStream), buyback permissions ($50M AMC), and hedging (Vitesse 67% 2026 oil hedged at $64-67/Bbl), contrasting dilutive raises (Olenox Series C, Functional Brands exchanges). M&A/asset sales (7 cases) show mixed pro forma impacts, e.g., Kaanapali $10.3M gain but sales declines YoY. No widespread margin compression; instead, operational enhancements (Battalion 30 drilling locations added) and forward contracts (ETHZilla 12-13% yields). Highest materiality events (10/10: IF Bancorp merger delist, Venture Global FID) imply sector rotation to energy/LNG; watch fintech tokenization and REIT dispositions for alpha.

50 high priority 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — March 13, 2026

Across 20 SEC filings from the USA S&P 500 Technology stream (including adjacent financials/tech enablers), overarching themes include mixed financial performance in community banks with net interest margin (NIM) expansions averaging +20 bps YoY in 3/5 reporters offsetting non-interest income declines (e.g., Chemung -65.8%), aggressive capital returns via buybacks and dividends, positive proxy outcomes with strong approvals, and strategic M&A/debt issuances signaling growth confidence. Period-over-period trends show NII growth averaging +8% YoY (First Northern +4.8%, Chemung +17.7%, NorthEast -2%), but net income declines in 4/8 reporters (Chemung -36.2%, NorthEast -5.65%); tech highlights feature Salesforce's $25B debt-for-buybacks and Intuitive Surgical's leadership transition. Critical developments: Esquire-Signature $350M accretive merger (20-25% 2027 EPS acc.), Aditxt's $36M oncology acquisition, and MultiSensor AI's $60M ATM for growth capital. Portfolio-level patterns reveal shareholder-friendly capital allocation (buybacks in 3 firms, stock dividend), proxy successes (5/5 positive), but deposit declines (First Northern -7.3%) and revenue softness (RideNow -10.5% YoY) flag liquidity pressures. Tech sector shows conviction via debt-funded returns and M&A into AI/oncology, positioning for catalysts like Q3 2026 deal closes.

16 high priority 4 medium 20 total filings
· daily

Nasdaq 100 Stocks SEC Filings — March 13, 2026

Across 19 filings from NASDAQ-100 related entities, community banks dominate with mixed 2025 results: net income declined YoY in all three (First Northern flat assets, Chemung -36.2% to $15.1M due to $17.5M securities loss offset by NII +17.7%, NorthEast -5.65% to $44.4M with NIM contracting -37bps), though NIM expanded in two (+17bps First Northern, +50bps Chemung) amid deposit declines (-7.3% First Northern). Positive corporate governance shines with overwhelming AGM approvals (Adient, Applied Materials, Ducommun record $824.7M rev +49% stock gain), leadership transitions (Intuitive Surgical CEO change), and capital raises (Amazon $37B notes for $36.8B net proceeds, NexMetals cash +551% to $39.8M post $80M financing). Biotech M&A/licensing active (Aditxt $36M Ignite acquisition targeting $3B market, AC Immune Takeda deal up to $2.1B milestones). Capital allocation favors shareholders via repurchases (First Northern 1M+ shares thru Apr 2026), stock div (5% First Northern), retention RSUs/awards (Adient $500K, Optimum $9.4M DCAs). Portfolio trend: financials show resilient NII growth (avg +8.8% YoY) despite one-offs, tech/industrials bullish on strategy execution. Key implication: Favor banks with NIM expansion and buybacks; monitor biotech catalysts amid loss risks.

13 high priority 6 medium 19 total filings
· daily

Dow Jones 30 Stocks SEC Filings — March 13, 2026

Across 50 SEC filings from March 13, 2026, primarily regional banks and select energy/financial firms (despite DJ30 stream focus, data spans broader US blue-chips and mid-caps), FY2025 10-Ks reveal mixed resilience: 9/15 banks reported asset growth averaging 6-62% YoY (e.g., ChoiceOne +62%), NIM expansions in 7/15 (avg +20bps, e.g., Red River +14% to 3.38%), but provisions spiked sharply in outliers (ChoiceOne +2,367% to $14.8M). Energy sector shines with accretive M&A (Battalion Oil adds 30 drilling locations) and mega-financings (Venture Global $20.7B CP2 LNG FID). Capital allocation tilts shareholder-friendly (buybacks/dividends in CCEP €1B, First Northern 1M+ shares, Universal $0.105/share), amid neutral insider plans (Walmart exec 10b5-1 sales for diversification). Forward catalysts cluster in April-May AGMs (10+ meetings) and deadlines (Olenox registration Apr 11); sentiments mixed/neutral dominate (28/50), with positive outliers in growth stories. Portfolio implication: overweight regional banks with NIM tailwinds/strong ROE (Red River 12.58%), monitor provision risks; energy M&A offers alpha amid LNG demand.

38 high priority 12 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — March 13, 2026

Across 50 SEC filings for March 13, 2026, key themes include mixed FY2025 results with revenue growth averaging +15% YoY in reporting companies (e.g., ONE Group +19.7%, Emerald +16.2%, Tonix +30% product rev) offset by Q4 weakness and margin pressures in hospitality/REITs, alongside robust capital allocation via dividends (GIII $0.10/share, Emerald $0.015/share, First Northern 5% stock dividend) and buybacks (Emerald $17.5M repurchased, $25M remaining; News Corp $1B program). Energy sector shines with Venture Global's $20.7B CP2 LNG financing (no equity dilution) positioning it as top US exporter at 100+ MTPA, and Battalion Oil's accretive acquisition adding 30 drilling locations. Pharma/biotech shows launches (Tonix TONMYA) but high cash burn; banks/REITs mixed with NIM expansion (First Northern +17 bps to 3.77%) but deposit declines. Forward guidance optimistic in hospitality/events (ONE Group $840-855M rev 2026, Emerald $490-495M), while insider activity neutral (Walmart 10b5-1 plans for diversification). Portfolio-level: 6/10 detailed filers issued upbeat 2026 guidance, but 4/10 reported net losses widening YoY; M&A/acquisitions in 5 filings signal consolidation. Implications: Favor energy/infrastructure over cyclical hospitality amid quiet deposit growth in banks.

32 high priority 18 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 13, 2026

Across 50 filings in the S&P 500 Consumer Discretionary stream (heavily skewed toward financials, retail/auto/entertainment), FY2025 results show mixed trends with robust revenue/NII growth averaging +30-50% YoY in outperformers like Jefferson Capital (+41.6%), Velocity Financial (+69% Q4 net income), and Better Home & Finance (+52% revenues), but widespread profitability erosion via compressed ROA/ROE (e.g., CHOICEONE ROA -31bps to 0.69%), exploding provisions (CHOICEONE +2367% to $14.8M), and rising expenses. Capital allocation leans bullish with buybacks (Ford 31.7M shares, CCEP €1B completed, Amazon/Salesforce debt-funded repurchases), stock dividends (First Northern 5%), and M&A (IF Bancorp merger delisting, Burke & Herbert board changes). Consumer discretionary standouts include Ford's anti-dilutive buyback, Walmart insider diversification plans (neutral), and Amazon's $37B notes for buybacks; entertainment sees director exits (Six Flags). Forward catalysts cluster in Q1-Q2 2026 (Better Home $1.4-1.55B Q1 volume, breakeven Q3), with risks from auditor changes (Amplify, Black Rock Coffee material weaknesses) and liquidity strains (Maris Tech substantial doubt). Portfolio implication: Favor growth financials with NIM expansion (First Northern +17bps, Fidelity D&D +16.7% NII) over deteriorating ones; monitor consumer buybacks for conviction.

36 high priority 14 medium 50 total filings